C4 Therapeutics (CCCC) EBITDA Margin (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,773.00 |
| Dec 31, 2025 | 9,860.00 |
| Sep 30, 2025 | 11,834.00 |
| Jun 30, 2025 | -3,993.00 |
| Mar 31, 2025 | 31,178.00 |
| Dec 31, 2024 | -52,085.00 |
| Sep 30, 2024 | -668.00 |
| Jun 30, 2024 | 79,350.00 |
| Mar 31, 2024 | 10,036.00 |
| Dec 31, 2023 | -80,558.00 |
| Sep 30, 2023 | 108,596.00 |
| Jun 30, 2023 | -44,140.00 |
| Mar 31, 2023 | 37,744.00 |
| Dec 31, 2022 | -77,291.00 |
| Sep 30, 2022 | -28,055.00 |
| Jun 30, 2022 | 24,580.00 |
| Mar 31, 2022 | -36,961.00 |
| Dec 31, 2021 | 21,033.00 |
| Sep 30, 2021 | -6,080.00 |
| Jun 30, 2021 | 5,324.00 |
| Mar 31, 2021 | -2,010.00 |
| Dec 31, 2020 | -536.00 |
| Sep 30, 2020 | -14,674.00 |
| Jun 30, 2020 | 6,313.00 |
| Mar 31, 2020 | -5,272.00 |
| Dec 31, 2019 | 6,604.00 |